Chimin Health Management Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
August 20, 2020 at 08:58 am
Share
Chimin Health Management Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 343.229 million compared to CNY 379.155 million a year ago. Operating income was CNY 17.233 million compared to CNY 36.896 million a year ago. Net income was CNY 10.848 million compared to CNY 24.453 million a year ago. Basic earnings per share from continuing operations was CNY 0.03 compared to CNY 0.08 a year ago.
Chimin Health Management Co., Ltd., formerly Zhejiang Chimin Pharmaceutical CO., Ltd, is primarily engaged in the research, development, manufacture and sale of infusion and injection and puncture machinery products. The Company primarily produces Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, as well as injection and puncture machinery products, including safety syringe, sterile syringes and infusion sets. The Company distributes its products within domestic market and to overseas markets.
CHIMIN HEALTH MANAGEMENT CO., LTD. 
